GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blueberries Medical Corp (OTCPK:BBRRF) » Definitions » ROE % Adjusted to Book Value

BBRRF (Blueberries Medical) ROE % Adjusted to Book Value : -7.15% (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Blueberries Medical ROE % Adjusted to Book Value?

Blueberries Medical's ROE % for the quarter that ended in Sep. 2024 was -53.28%. Blueberries Medical's PB Ratio for the quarter that ended in Sep. 2024 was 7.45. Blueberries Medical's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -7.15%.


Blueberries Medical ROE % Adjusted to Book Value Historical Data

The historical data trend for Blueberries Medical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueberries Medical ROE % Adjusted to Book Value Chart

Blueberries Medical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -134.78 -25.26 -24.21 -26.97 -27.91

Blueberries Medical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.84 -36.09 -10.62 -18.46 -7.15

Competitive Comparison of Blueberries Medical's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blueberries Medical's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Blueberries Medical's ROE % Adjusted to Book Value falls into.



Blueberries Medical ROE % Adjusted to Book Value Calculation

Blueberries Medical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-96.29% / 3.45
=-27.91%

Blueberries Medical's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-53.28% / 7.45
=-7.15%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blueberries Medical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Blueberries Medical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Blueberries Medical Business Description

Traded in Other Exchanges
Address
8500 West Georgia Street, Suite 2200, Vancouve, BC, CAN, V6C 3E8
Blueberries Medical Corp is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.

Blueberries Medical Headlines

From GuruFocus

Blueberries Medical Provides Corporate Update

By Marketwired Marketwired 04-01-2020

Blueberries Medical Reports Q1-2023

By sperokesalga sperokesalga 05-30-2023